BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18024407)

  • 21. Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.
    Stam RW; den Boer ML; Schneider P; Nollau P; Horstmann M; Beverloo HB; van der Voort E; Valsecchi MG; de Lorenzo P; Sallan SE; Armstrong SA; Pieters R
    Blood; 2005 Oct; 106(7):2484-90. PubMed ID: 15956279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinations of the FLT3 inhibitor CEP-701 and chemotherapy synergistically kill infant and childhood MLL-rearranged ALL cells in a sequence-dependent manner.
    Brown P; Levis M; McIntyre E; Griesemer M; Small D
    Leukemia; 2006 Aug; 20(8):1368-76. PubMed ID: 16761017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
    Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
    Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk-adapted therapeutic stratification of infantile acute lymphocytic leukemia based on MLL-gene rearrangement].
    Tomizawa D
    Rinsho Ketsueki; 2008 Mar; 49(3):171-81. PubMed ID: 18421958
    [No Abstract]   [Full Text] [Related]  

  • 25. Environmental and genetic susceptibility to MLL-defined infant leukemia.
    Ross JA
    J Natl Cancer Inst Monogr; 2008; (39):83-6. PubMed ID: 18648010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes.
    Albouhair S; Morgado E; Lavau C
    PLoS One; 2013; 8(8):e72261. PubMed ID: 23977266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.
    Armstrong SA; Kung AL; Mabon ME; Silverman LB; Stam RW; Den Boer ML; Pieters R; Kersey JH; Sallan SE; Fletcher JA; Golub TR; Griffin JD; Korsmeyer SJ
    Cancer Cell; 2003 Feb; 3(2):173-83. PubMed ID: 12620411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.
    Schotte D; Chau JC; Sylvester G; Liu G; Chen C; van der Velden VH; Broekhuis MJ; Peters TC; Pieters R; den Boer ML
    Leukemia; 2009 Feb; 23(2):313-22. PubMed ID: 18923441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of RAS mutations in MLL-rearranged leukaemia: A path to intervention?
    Mansur MB; Ford AM; Emerenciano M
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):521-526. PubMed ID: 29056538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.
    Gutierrez-Camino A; Richer C; Ouimet M; Fuchs C; Langlois S; Khater F; Caron M; Beaulieu P; St-Onge P; Bataille AR; Sinnett D
    Br J Cancer; 2024 Feb; 130(2):317-326. PubMed ID: 38049555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular epidemiology of neonatal leukemia in Brazil.
    Moura SV; Andrade F; Magalhães IQ; Costa I; Silva DB; D'Andrea ML; Pinheiro VP; Lee ML; Werneck F; Emerenciano M; Pombo-de-Oliveira MS
    Leuk Lymphoma; 2015 Apr; 56(4):903-9. PubMed ID: 24991719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
    Ishikawa Y; Kiyoi H; Tsujimura A; Miyawaki S; Miyazaki Y; Kuriyama K; Tomonaga M; Naoe T
    Eur J Haematol; 2009 Aug; 83(2):90-8. PubMed ID: 19309322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors.
    Brassesco MS; Montaldi AP; Gras DE; Camparoto ML; Martinez-Rossi NM; Scrideli CA; Tone LG; Sakamoto-Hojo ET
    Mutagenesis; 2009 Mar; 24(2):153-60. PubMed ID: 19028982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia.
    Richter WF; Shah RN; Ruthenburg AJ
    Elife; 2021 Jul; 10():. PubMed ID: 34263728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.
    Andersson AK; Ma J; Wang J; Chen X; Gedman AL; Dang J; Nakitandwe J; Holmfeldt L; Parker M; Easton J; Huether R; Kriwacki R; Rusch M; Wu G; Li Y; Mulder H; Raimondi S; Pounds S; Kang G; Shi L; Becksfort J; Gupta P; Payne-Turner D; Vadodaria B; Boggs K; Yergeau D; Manne J; Song G; Edmonson M; Nagahawatte P; Wei L; Cheng C; Pei D; Sutton R; Venn NC; Chetcuti A; Rush A; Catchpoole D; Heldrup J; Fioretos T; Lu C; Ding L; Pui CH; Shurtleff S; Mullighan CG; Mardis ER; Wilson RK; Gruber TA; Zhang J; Downing JR;
    Nat Genet; 2015 Apr; 47(4):330-7. PubMed ID: 25730765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute lymphoblastic leukemia in infancy.
    Silverman LB
    Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1070-3. PubMed ID: 17943956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
    Scholl S; Theuer C; Scheble V; Kunert C; Heller A; Mügge LO; Fricke HJ; Höffken K; Wedding U
    Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs.
    Bueno C; Ayllón V; Montes R; Navarro-Montero O; Ramos-Mejia V; Real PJ; Romero-Moya D; Araúzo-Bravo MJ; Menendez P
    Blood; 2013 May; 121(19):3867-78, S1-3. PubMed ID: 23479570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of FLT3 gene abnormalities in Brazilian patients with infant leukemia.
    Emerenciano M; Menezes J; Vasquez ML; Zalcberg I; Thuler LC; Pombo-de-Oliveira MS;
    Leuk Lymphoma; 2008 Dec; 49(12):2291-7. PubMed ID: 19052976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of global hypomethylation in promoter hypermethylated Mixed Lineage Leukaemia-rearranged infant acute lymphoblastic leukaemia.
    Stumpel DJ; Schneider P; van Roon EH; Pieters R; Stam RW
    Eur J Cancer; 2013 Jan; 49(1):175-84. PubMed ID: 22921182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.